Lymphoma-associated acquired von Willebrand syndrome responsive to splenectomy: A case report.

acquired von Willebrand syndrome case report hemostasis

Journal

EJHaem
ISSN: 2688-6146
Titre abrégé: EJHaem
Pays: United States
ID NLM: 101761942

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 28 04 2022
revised: 05 05 2022
accepted: 12 05 2022
entrez: 2 9 2022
pubmed: 3 9 2022
medline: 3 9 2022
Statut: epublish

Résumé

A previously healthy 33-year-old female presented with a large hematoma over her right knee after kneeling. She was found to have pancytopenia and massive splenomegaly. Von Willebrand Factor (VWF) antigen level was 0.38 units/ml, ristocetin cofactor activity 0.13 units/ml, and VWF multimeric distribution was normal. Bone marrow examination revealed an indolent B-cell lymphoma. Diagnosis was consistent with acquired von Willebrand syndrome as an autoimmune epiphenomenon of a lymphoma. Diagnostic and therapeutic splenectomy under hemostatic coverage was performed. VWF antigen levels and activities immediately normalized postoperatively and remained within the normal range several months later. Splenic pathology confirmed hairy cell leukemia with a BRAF mutation.

Identifiants

pubmed: 36051021
doi: 10.1002/jha2.486
pii: JHA2486
pmc: PMC9421994
doi:

Types de publication

Journal Article

Langues

eng

Pagination

996-999

Informations de copyright

© 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.

Références

Case Rep Hematol. 2018 Jan 30;2018:7973297
pubmed: 29651351
Thromb Haemost. 2000 Aug;84(2):175-82
pubmed: 10959686
Haematologica. 2020 Aug;105(8):2032-2037
pubmed: 32554559
Blood. 2011 Jun 23;117(25):6777-85
pubmed: 21540459
Blood Cancer J. 2020 May 27;10(5):62
pubmed: 32461544
Semin Thromb Hemost. 2002 Apr;28(2):227-38
pubmed: 11992245
BMJ Case Rep. 2021 Jan 27;14(1):
pubmed: 33504531
N Engl J Med. 2016 Nov 24;375(21):2067-2080
pubmed: 27959741
Blood Adv. 2021 Jan 12;5(1):280-300
pubmed: 33570651
Thromb Haemost. 2000 Aug;84(2):345-9
pubmed: 10959711

Auteurs

Fatima Khadadah (F)

Division of Hematology Kuwait Cancer Control Centre Shuwaikh Kuwait.

Natasha Rupani (N)

Division of Hematology Department of Medicine University of Toronto Toronto Canada.

Jordan Scott (J)

Division of Hematology Department of Medicine University of Toronto Toronto Canada.

Martina Trinkaus (M)

Division of Hematology/Oncology, Departments of Medicine and Laboratory Medicine & Pathobiology St. Michael's Hospital, University of Toronto Toronto Canada.

Jerome Teitel (J)

Division of Hematology/Oncology, Departments of Medicine and Laboratory Medicine & Pathobiology St. Michael's Hospital, University of Toronto Toronto Canada.

Michelle Sholzberg (M)

Division of Hematology/Oncology, Departments of Medicine and Laboratory Medicine & Pathobiology St. Michael's Hospital, University of Toronto Toronto Canada.

Classifications MeSH